e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Synthetic cannabinoids induce acute lung inflammation
via
cannabinoid receptor 1 activation
Charles N. Zawatsky, Jasmina Abdalla, Resat Cinar
Source:
ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020
Journal Issue:
July
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Charles N. Zawatsky, Jasmina Abdalla, Resat Cinar. Synthetic cannabinoids induce acute lung inflammation
via
cannabinoid receptor 1 activation. ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The role of purinergic P2X
7
receptors on lipopolysaccharide (LPS)-induced lung injury
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
Effects of Liver X receptor agonist treatment on signal transduction pathways in acute lung inflammation
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Concomitant exposure to nicotine and endotoxin in vitro induces murine airway hyperreactivity possibly via nicotine-induced upregulation of toll-like receptors
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Influence of Toll-like receptor 4 (TLR4) on cellular signaling of acute lung injury
Source: Eur Respir J 2003; 22: Suppl. 45, 268s
Year: 2003
Opioid receptors antagonist N-acylstearoilethanolamine (NAE) modulates Th1/Th2 cell function in COPD after radiation exposure
Source: Eur Respir J 2004; 24: Suppl. 48, 133s
Year: 2004
The endocannabinoids anandamide and 2-arachidonyl-glycerol (2-AG) induce pulmonary hypertension (PH) in a CB1 receptor independent manner - role of COX-2 and EP1 receptor activation
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005
Role of Toll-like receptor 4 in acute pulmonary inflammation induced by bacterial components in mice
Source: Eur Respir J 2005; 26: Suppl. 49, 730s
Year: 2005
Muscarinic receptor subtype-specific effects on cigarette smoke-induced inflammation in mice
Source: Eur Respir J 2013; 42: 1677-1688
Year: 2013
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
Source: Eur Respir J 2008; 32: 426-436
Year: 2008
EP2 & EP4 receptor agonists inhibit the airway sensory nerves that cause cough, a potential protective control that is lost in human smokers and a pre-clinical COPD model
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
Surfactant protein A modulate bleomycin-induced lung injury in toll-like receptor 2 dependent pathway
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Effects of the novel toll-like receptor 7 (TLR7) agonist AZD8848 on allergen-induced responses in patients with mild asthma
Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD
Year: 2012
Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes
via
stimulation of different 5-HT receptor subtypes
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005
The effects of formyl peptide receptor agonist on the asthma pathogenesis
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
The GLP-1 receptor agonist Liraglutide attenuates intermittent hypoxia-induced pro-inflammatory macrophage polarization in primary macrophages
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021
Toll-like receptor stimulation induces airway hyperresponsiveness to bradykinin, an effect mediated by JNK and NF-κB signaling pathways
Source: Eur Respir J 2005; 26: Suppl. 49, 732s
Year: 2005
Novel approach to prevention of dust-induced acute lung injury with interleukin-1 receptor antagonist (IL-1ra)
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003
Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005
Protease-activated receptor 1 activation exaggerates allergic airway inflammation in mice
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept